You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
業聚醫療(06929.HK)與深圳開立生物簽訂IVUS系統獨家分銷協議
阿思達克 07-21 17:18
業聚醫療(06929.HK)宣布與深圳開立生物醫療科技簽訂新的獨家分銷協議,業聚醫療將在亞太區及歐洲地區共12個市場獨家代理開立醫療旗下血管內超聲(IVUS)系統。 業聚醫療於去年12月取得該產品於香港及澳門的獨家分銷權,現時與開立醫療的合作範圍進一步拓展至法國、德國、馬來西亞、西班牙、新加坡及瑞士等6個直銷市場,以及歐洲區內的6個分銷市場。集團表示,期望藉此豐富產品組合及創造交叉銷售機會,透過完善的全球分銷網絡,為更廣泛地區的患者提供創新心血管治療方案。 為實踐全球業務發展策略及提高患者醫療可及性的承諾,業聚醫療表示正與開立醫療就亞太其他地區的潛在合作持續磋商。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account